Impact of Therapeutic Education, Being Set up Under the Authorized Program for Diabetics Patients in Hospital (ImETh)

July 22, 2022 updated by: Hôpital Léon Bérard

Impact Des Actions d'éducation thérapeutique Mises en Place Dans le Cadre d'un Programme autorisé auprès de Patients diabétiques hospitalisés

To Assess the impact of therapeutic education on:

  • the occurrence of long term diabetes complications .
  • balance of his diabetes

Study Overview

Status

Withdrawn

Conditions

Intervention / Treatment

Detailed Description

evaluation of the benefits of therapeutic education by:

  • glycated hemoglobin assay
  • telephone monitoring
  • quiz
  • monitoring of adverse event related to diabete

Study Type

Observational

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

diabetics hospitalized patients

Description

Inclusion Criteria: Patients

  • diabetic
  • hospitalized in Léon Berard
  • with telephone line
  • written consent given
  • belong to a social security system

Exclusion Criteria:

  • no diabetics
  • patient having alredy completing a therapeutic education program
  • minor patient (<18 years)
  • pregnant woman
  • without telephone line
  • no belong to a social security system
  • patient alredy inclued on clinical study.
  • patient tutelage or under curatorship

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Therapeutic Education + Documentation
diabetic patient hospitalized patient particpating in therapeutic education program
Other: Therapeutic Education
participation in a therapeutic education program on diabetes
No Therapeutic Education No Documents
diabetic patient hospitalized patient without therapeutic education program no documentation submitted
Documentation, No Therapeutic Education
diabetic patient hospitalized patient without therapeutic education program documentation submitted

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
glycated hemoglobin measure
Time Frame: 3 months
blood sample
3 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
hopitalization
Time Frame: 3 months
hospitlization related to diabetes
3 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Hôpital Léon Bérard

Investigators

  • Principal Investigator: Alkassoum Sapha, Medecin, medecin

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

March 1, 2015

Primary Completion (Anticipated)

September 1, 2016

Study Completion (Anticipated)

November 1, 2016

Study Registration Dates

First Submitted

June 1, 2015

First Submitted That Met QC Criteria

June 2, 2015

First Posted (Estimate)

June 3, 2015

Study Record Updates

Last Update Posted (Actual)

July 26, 2022

Last Update Submitted That Met QC Criteria

July 22, 2022

Last Verified

July 1, 2022

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • Protocole#5-Version1.0

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Diabetes Complications

Clinical Trials on Therapeutic Education

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Madagascar

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe